Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - Canadian Cardiovascular Congress (CCC)
The LDL-C Treatment Gap Expected to Be Essentially Closed with New Lipid-Lowering Agents
Vancouver, BC / October 25-28, 2014
Vancouver - Lipid-lowering therapies now in late stages of development are expected to bring the majority of patients to guideline-recommended treatment goals regardless of the reason why they are unable to reach their goal on current...
PRIORITY PRESS - 39th Annual Congress of the European Society for Medical Oncology (ESMO)
Survival Data Justify Early Use of Androgen Pathway Inhibitor in Metastatic Castration Resistant Prostate Cancer
Madrid, Spain / September 26-30, 2014
Madrid - The final overall survival (OS) results of a phase 3 multicentre trial have confirmed the value of first-line androgen inhibition in metastatic castration resistant prostate cancer (mCRPC). In the study, early use of an androgen...
PRIORITY PRESS - 39th Congress of the European Society for Medical Oncology (ESMO)
Objective Response to a TKI in Metastatic Renal Cell Cancer Is Substantially Improved with Individualized Dose Schedules
Madrid, Spain / September 26-30, 2014
Madrid - Optimal response to a tyrosine kinase inhibitor (TKI) employed first line in metastatic renal cell carcinoma (mRCC) appears to be achieved by individualizing the dose and schedule in order to sustain dose intensity, according to...
PRIORITY PRESS - 39th Congress of the European Society for Medical Oncology (ESMO)
Targeted Therapies Moving into First-Line Therapy Underscore Need for Baseline Molecular Testing of Lung Cancers
Madrid, Spain / September 26-30, 2014
Madrid - Guidelines issued by ESMO just prior to the annual Congress call for routine molecular testing at the time of diagnosis in all patients with non-small cell lung cancer (NSCLC). New phase 3 data on ALK-positive (ALK+) NSCLC...
MEDI-NEWS - Based on an interim safety surveillance report by L'Institut national de santé publique du Québec (INSPQ) (Funded by the Quebec Ministry of Health and Social Services) Original report in French at http://www.inspq.qc.ca/pdf/publications/1885_Vaccin_Menincogoque_SerogroupeB.pdf
Interim Surveillance Report on the Safety of a Large-Scale Vaccination Campaign Against Serogroup B Neisseria meningitidis
September 2014
Quebec City - Invasive meningococcal disease (IMD) caused by serogroup B Neisseria meningitidis is the most common IMD in Canada today. The incidence of serogroup B disease is also highest in infants under the age of 12 months, children...
MEDICAL FRONTIERS - 36th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)
Early Diagnosis and Treatment of Risk Factors for Osteoporosis Offer Major Opportunity Reduce Fracture Risk in China
Houston, Texas / September 12-15, 2014
Houston - Several factors explain the rapidly rising rate of fractures due to osteoporosis in China. One is the increasing proportion of the population over the age of 60. Another is the high rate of vitamin D deficiency, a nutrient...
MEDICAL FRONTIERS - 36th Annual Congress of the European Society of Cardiology (ESC)
More Aggressive Strategies for Early Detection of Pulmonary Hypertension Supported by Outcome Trials
Barcelona, Spain / August 30-September 3, 2014
Barcelona - Pulmonary arterial hypertension (PAH) should be treated earlier and more aggressively, according to a new analysis of clinical trials with mortality and morbidity endpoints. By demonstrating that outcomes are better when...
PRIORITY PRESS - 36th Annual Congress of the European Society of Cardiology (ESC)
New Options Emerging for Cholesterol Lowering in Patients Not Adequately Controlled on Statins
Barcelona, Spain / August 30-September 3, 2014
Barcelona - A new therapeutic drug class can reduce low-density lipoprotein cholesterol (LDL-C) levels by more than 60% in patients on maximally tolerated statins, according to a series of phase 3 trials conducted in high-risk patient...
PRIORITY PRESS - 29th International Papillomavirus Conference (HPV 2014)
Dramatic Reductions in Cervical Cancer Possible with New 9-valent HPV Vaccine
Seattle, Washington / August 21-25, 2014
Seattle - Worldwide, the human papilloma virus (HPV) causes over 600,000 cases of cancer in men and women every year, cervical cancer by far and away being the most common. Prevention of approximately 70% of all cervical cancer is now...